GlassScriptPhysician profile
Michael Dan Cantor
NPI 1760635486
$7,504.38
in general payments reported to CMS, 2019-2025
37 companies · $1,063 in 2025
The $1,063 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,336 · 2020: $76.45 · 2021: $1,687 · 2022: $1,023 · 2023: $1,094 · 2024: $1,225 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,369 · Education: $12.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,368.77 |
| Education | $12.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,325.07 | 2019-2024 | Xarelto |
| Abbott Laboratories | $1,252.50 | 2019-2025 | Cardiomems, Xience Skypoint, Confirm Rx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,186.48 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $933.97 | 2019-2020 | |
| Pfizer INC. | $518.83 | 2019-2025 | |
| Amgen INC. | $265.21 | 2019-2025 | Repatha, Repatha |
| Abiomed | $193.78 | 2025 | |
| Heartflow, INC. | $188.24 | 2023-2025 | Ffrct |
| Novartis Pharmaceuticals Corporation | $155.14 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.08 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $130.16 | 2022-2025 | Avvigo Guidance System, Watchman Flx, Synergy |
| Kestra Medical Technology Services, INC. | $109.92 | 2023-2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $102.04 | 2019-2025 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $99.61 | 2022-2025 | |
| Ekos Corporation | $92.23 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $79.02 | 2023 | Rybelsus, Ozempic |
| Cvrx, INC. | $77.10 | 2023-2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $76.87 | 2022-2024 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $68.03 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $67.18 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $49.34 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $48.86 | 2023-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $48.51 | 2022-2025 | Wainua |
| Medtronic, INC. | $47.52 | 2021-2023 | In.Pact Admiral |
| Terumo Medical Corporation | $40.53 | 2019-2025 | Glidewire, Metacross Otw |
| Lilly USA, LLC | $31.75 | 2022 | |
| Inari Medical, INC. | $22.12 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Daiichi Sankyo INC. | $22.10 | 2021 | |
| Irhythm Technologies, INC. | $21.57 | 2024 | Zio Xt Patch, Zio Monitor |
| Chiesi USA, INC. | $17.00 | 2025 | Juxtapid |
| Takeda Pharmaceuticals U.S.A., INC. | $16.97 | 2022 | |
| Eisai INC. | $16.70 | 2021 | |
| Scpharmaceuticals INC. | $15.73 | 2025 | |
| Baxter Healthcare | $15.29 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Tactile Systems Technology INC | $14.65 | 2021 | |
| Medicure Pharma INC. | $11.70 | 2022 | |
| Cardinal Health 200 LLC | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cantor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.